Analyst rating
Based on 2 analysts giving stock ratings to ITCI in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ITCI EPS for the last quarter is −3.30 MXN despite the estimation of −1.71 MXN. In the next quarter EPS is expected to reach −1.03 MXN. Track more of INTRA-CELLUAR THERAPIES INC financials and stay on top of what is up with the company.
In the next quarter INTRA-CELLUAR THERAPIES INC revenue is expected to reach 4.32 B MXN. Check out INTRA-CELLUAR THERAPIES INC revenue and earnings and make informed decisions.